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Glycine receptors (GlyRs) containing the α2 subunit regulate cortical interneuron
migration. Disruption of the GlyR α2 subunit gene (Glra2) in mice leads to disrupted
dorsal cortical progenitor homeostasis, leading to a depletion of projection neurons
and moderate microcephaly in newborn mice. In humans, rare variants in GLRA2,
which is located on the X chromosome, are associated with autism spectrum disorder
(ASD) in the hemizygous state in males. These include a microdeletion (GLRA2∆ex8-9)
and missense mutations in GLRA2 (p.N109S and p.R126Q) that impair cell-surface
expression of GlyR α2, and either abolish or markedly reduce sensitivity to glycine. We
report the functional characterization of a third missense variant in GLRA2 (p.R323L),
associated with autism, macrocephaly, epilepsy and hypothyroidism in a female
proband. Using heterosynapse and macroscopic current recording techniques, we
reveal that GlyR α2R323L exhibits reduced glycine sensitivity, but significantly increased
inhibitory postsynaptic current (IPSC) rise and decay times. Site-directed mutagenesis
revealed that the nature of the amino acid switch at position 323 is critical for impairment
of GlyR function. Single-channel recordings revealed that the conductance of α2R323Lβ
channels was higher than α2β channels. Longer mean opening durations induced by
p.R323L may be due to a change in the gating pathway that enhances the stability of
the GlyR open state. The slower synaptic decay times, longer duration active periods
and increase in conductance demonstrates that the GlyR α2 p.R323L mutation results
in an overall gain of function, and that GlyR α2 mutations can be pathogenic in the
heterozygous state in females.
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INTRODUCTION
Glycine receptors (GlyRs) are key members of a ligand-gated ion channel superfamily that includes
nicotinic acetylcholine receptors (nAChRs), 5-hydroxytryptamine type-3 receptors (5-HT3Rs) and
γ-aminobutyric acid type-A receptors (GABAARs). There are four GlyR α subunits (α1–α4) and
one β subunit, that share a common topology: a large N-terminal extracellular domain (ECD)
that harbors the ligand-binding site and four transmembrane domains (M1–M4) connected
by short intracellular (M1–M2) and extracellular (M2–M3) loops and a long intracellular loop
connecting M3 to M4 (Lynch, 2009). GlyRs can be formed as homomers, consisting of α subunits
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only, or as heteromers comprising α and β subunits in a 3α:2β or
2α:3β stoichiometry (Grudzinska et al., 2005; Durisic et al., 2012;
Yang et al., 2012). Key biological roles of different GlyR isoforms
have been revealed by the study of GlyR dysfunction in rodent
models and human disease. For example, the major adult GlyR
isoform consisting of α1 and βGlyR subunits, has a major role in
the control of spinal motor reflex circuits. Mutations in the genes
encoding this GlyR subtype (GLRA1 and GLRB) cause startle
disease, characterized by noise- or touch-induced non-epileptic
seizures, excessive muscle stiffness and neonatal apnea episodes
in cattle, mice and humans (Harvey et al., 2008; Bode and Lynch,
2014). Allelic variants ofGLRB have also recently been associated
with agoraphobic behavior, an increased startle response and fear
network activation (Deckert et al., 2017).
By contrast, GlyR α3 subunit knockout mice have revealed a
role for this subtype in central inflammatory pain sensitization
(Harvey et al., 2004), rhythmic breathing (Manzke et al., 2010),
ethanol intake, preference and taste aversion (Blednov et al.,
2015) and auditory nerve function (Dlugaiczyk et al., 2016). The
GlyR α4 subunit has been linked to neurotransmitter release in
sympathetic neurons (Boehm et al., 1997; Harvey et al., 2000)
but is thought to be a pseudogene in humans (Simon et al.,
2004) due to a stop codon in GLRA4 exon 9, causing a protein
truncation between membrane-spanning domains M3 and M4.
Perhaps for this reason, no mouse knockout model currently
exists.
The GlyR α2 subtype has previously been linked to roles
in synaptogenesis (Kirsch and Betz, 1998; Levi et al., 1998),
cell fate and paracrine transmitter release (Mangin et al.,
2003) in the developing cortex and spinal cord (Flint et al.,
1998; Scain et al., 2010). GlyR α2 is also pivotal in the
modulation of ethanol intake, aversion and preference (Blednov
et al., 2015), retinal photoreceptor development (Young and
Cepko, 2004) and the control of receptive field surround in
retinal ganglion cells (Nobles et al., 2012; Zhang C. et al.,
2015). However, more recent studies using a novel Glra2
knockout line provided compelling evidence that extrasynaptic
activation of GlyRs containing the α2 subunit in interneurons
is vital for control of cortical tangential migration during
embryogenesis (Avila et al., 2013). In Glra2 knockout mice,
dorsal cortical progenitor homeostasis was disrupted (Avila
et al., 2014) impairing the capacity of apical progenitors to
generate basal progenitors. This resulted in a reduction of
projection neurons in upper or deep layers of the cerebral
cortex and moderate microcephaly in newborn Glra2 knockout
mice (Avila et al., 2014). Somatosensory cortical neurons in
Glra2 knockout mice also have more dendritic branches with an
overall increase in total spine number. This results in disruption
of the excitation/inhibition balance, with an overall increase
network excitability and enhanced susceptibility to epileptic
seizures (Morelli et al., 2017) as well as defects in long-term
potentiation and object recognition memory (Pilorge et al.,
2016).
The kinetic properties of homomeric α2 subunit GlyRs
have been studied at the single-channel and macropatch levels
(Mangin et al., 2003; Krashia et al., 2011). These studies
reveal that wild-type homomeric α2 GlyRs activate for longer
durations than α1-containing GlyRs (Krashia et al., 2011)
and activate and deactivate more slowly on an ensemble
macropatch level (Mangin et al., 2003). Changes in GlyR
subunit mRNA levels suggest a developmental switch in
expression from predominantly α2 in embryonic/neonatal
rodents to α1/α3 in juveniles/adults, whereas expression
of the β subunit remains high throughout this period of
development. Coupled with the observation that synaptic
current decay is relatively slow in neonatal neurons and
accelerates in neurons of juvenile rodents, it is reasonable
to infer a developmental switch from α2 homomers or α2β
heteromers to heteromeric α1β or α3β GlyRs (Singer et al.,
1998).
Consistent with these findings, microdeletions and missense
mutations in the human GlyR α2 subunit gene (GLRA2),
which is located on the X-chromosome, have been associated
with rare cases of autism spectrum disorder (ASD) in the
hemizygous state in males (Pinto et al., 2010; Piton et al.,
2011; Iossifov et al., 2014; Pilorge et al., 2016). To date,
a microdeletion (GLRA2∆ex8-9) and two de novo missense
mutations p.N109S and p.R126Q (p.N136S and p.R153Q in the
GlyR α2 subunit with signal peptide) have been functionally
characterized (Pilorge et al., 2016). GLRA2∆ex8-9 resulted in
the production of a truncated mRNA that escaped nonsense-
mediated RNA decay. However, this resulted in a truncated
GlyR α2 subunit protein lacking the third and fourth membrane-
spanning domains and the cytoplasmic M3–M4 intracellular
loop. Functional studies revealed that GlyR α2∆ex8-9 was not
expressed at the cell surface in CHO cells (Pilorge et al.,
2016). By contrast, the GlyR α2N109S and α2R126Q mutations
resulted in reduced cell-surface expression and substantially
reduced glycine sensitivity by one-to-two orders of magnitude
(Pilorge et al., 2016). These mutations were classified as loss-
of-function based on their impaired trafficking and inability
to respond to physiological levels of glycine. The aim of this
study was to functionally characterize a third missense variant
in GLRA2, (p.R323L), where the pathomechanism was unclear
since it was found in the heterozygous state in a female patient
and inherited from an apparently healthy mother (Piton et al.,
2011).
MATERIALS AND METHODS
Cell Culture and Molecular Biology
Expression constructs encoding the human GlyR α2 and β
subunits were combined in 1α:50β ratio (heterosynapse and
macropatch recordings) or 1α:100β (single-channel recordings)
and transfected into HEK293 cells via Ca2+ phosphate-DNA
co-precipitation. This resulted in a high level of expression of
heteromeric α2βGlyRs (Zhang Y. et al., 2015). For heterosynapse
experiments, expression constructs for the mouse neuroligin
2A (NL2A) splice variant and rat gephyrin were co-transfected
along with GlyR constructs to facilitate the formation of
heterosynapses. Empty pEGFP or CD4 plasmid was also
transfected as expression markers. Site-directed mutagenesis
was performed using the QuikChange kit (Agilent), and the
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successful incorporation of mutations was confirmed by Sanger
DNA sequencing. Mutation position in the GlyR α2 subunit
is indicated using mature subunit numbering (i.e., after signal
peptide cleavage).
Heterosynapse Formation
Primary cultures of spinal cord neurons were prepared as
previously described (Dixon et al., 2015; Zhang Y. et al., 2015).
E15 timed-pregnant rats were euthanized via CO2 inhalation
in accordance with procedures approved by the University of
Queensland Animal Ethics Committee. Cells were plated at
a density of ∼80,000 cells per 18 mm poly-D-lysine coated
coverslip in DMEM medium with 10% (v/v) foetal bovine
serum. After 24 h, the plating medium was changed to
Neurobasal medium supplemented with 2% (v/v) B27 and 1%
(v/v) GlutaMAX, and a second feed after 1 week replaced half
of this medium. Neurons were grown for 1–4 weeks in vitro and
heterosynaptic co-cultures were prepared by directly introducing
transfected HEK293 cells onto the primary neuronal cultures
1–3 days prior to recording.
Electrophysiology
Whole-cell recordings were performed on transfected
HEK293 cells in voltage-clamp mode using a HEKA
EPC10 amplifier (HEKA Electronics, Lambrecht, Germany)
and PATCHMASTER software (HEKA), at room temperature.
Cells were placed in an external solution comprising (in mM):
140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES and 10 D-glucose,
adjusted to pH 7.4 with NaOH. Patch pipettes (1–3 MΩ
resistance), were pulled from borosilicate glass (GC150F-
7.5, Harvard apparatus), and filled with an intracellular
solution containing the following (in mM): 145 CsCl, 2 CaCl2,
2 MgCl2, 10 HEPES, 10 EGTA and 2 MgATP, adjusted to
pH 7.4 with NaOH. Glycine-gated currents were recorded
at a holding potential of −40 mV, digitized at 4 kHz and
filtered at 10 kHz. For inhibitory postsynaptic current (IPSC)
recordings, patch-pipette resistances were adjusted to 4–6 MΩ
and filled with the same internal solution. Series resistance
was routinely compensated to 60% of maximum and was
monitored throughout the recording. Both spontaneous and
action potential-evoked glycinergic IPSCs in HEK293 cells
were recorded at a holding potential −60 mV and signals were
digitally sampled at 10 kHz and filtered at 4 kHz. As these
IPSCs were completely abolished by 1 µM tetrodotoxin (not
shown), we infer they were induced by spontaneous action
potentials.
Single-channel currents were recorded from outside-out
excised patches at a clamped potential of −70 mV. Glass
electrodes were pulled from borosilicate glass (G150F-3; Warner
Instruments), coated with a silicone elastomer (Sylgard-184; Dow
Corning) and heat-polished to a final tip resistance of 8–15 MΩ
when filled with an intracellular solution containing (in mM)
145 CsCl, 2 MgCl2, 2 CaCl2, 10 HEPES and 5 EGTA, pH
7.4. Excised patches were directly perfused with extracellular
solution by placing them in front of one barrel of a double-
barrelled glass tube. Single-channel currents were either recorded
while the patch was exposed to extracellular solution (without
added glycine) or elicited by exposing the patch continuously
to glycine (100 µM or 3 mM) containing solution. Experiments
were recorded using an Axopatch 200B amplifier (Molecular
Devices), filtered at 5 kHz and digitized at 20 kHz using
Clampex (pClamp 10, Molecular Devices) via a Digidata 1440A
digitizer. The currents were filtered off-line at 3 kHz for
analysis.
Macropatch recordings were performed in the excised
outside-out patch-clamp configuration. Patch pipettes were
fire-polished to a resistance of approximately 10 MΩ and
filled with the same internal solution. Macroscopic currents in
outside-out patches pulled from transfected HEK293 cells were
activated by brief (<1 ms) exposure to agonists using a piezo-
electric translator (Siskiyou). The speed of the solution exchange
system was regularly calibrated by rapidly switching the solution
perfusing an open patch pipette between standard extracellular
solution and an extracellular solution that had been diluted by
50% with distilled water. By monitoring the resulting pipette
current, we were able to ensure that the solution perfusing the
macropatch was completely exchanged within 200 µs (Dixon et
al., 2014). Recordings were performed using a Multiclamp 700B
amplifier and pClamp9 software (Molecular Devices), filtered at
4 kHz and sampled at 10 kHz.
Analysis
Analyses of IPSC amplitudes, 10%–90% rise times, and weighted
decay time constants were performed using Axograph (Axograph
Scientific). Only cells with a stable series resistance of <25 MΩ
throughout the recording period were included in the analysis.
Single peak IPSCs with amplitudes of at least three times above
the background noise were detected using a semi-automated
sliding template. Each detected event was visually inspected
and only well-separated IPSCs with no inflections in the
rising or decay phases were included. To calculate macroscopic
current decay time constants, averaged macroscopic traces were
fitted with double-exponential functions in Axograph X, and
a weighted time constant was calculated from individual time
constants (τ1, τ2) and their relative amplitude (A1, A2) as
follows: τweighted = (τ1×A1 + τ2×A2)/(A1 + A2). The averaged
data from individual cells were then pooled to obtain group data.
Statistical analysis, and plotting were performed with Prism 5
(GraphPad Software). The fitting of single Gaussian functions
to IPSC amplitude and decay time constant distributions was
also performed using Prism 5. All data are presented as
mean ± SEM. Student’s unpaired t-tests or one-way ANOVAs,
as appropriate, were employed for comparisons. For all tests,
the number of asterisks corresponds to level of significance:
∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 and ∗∗∗∗p < 0.0001.
Single-channel recordings were analyzed with pClamp 10
(Clampfit, Molecular Devices) or QuB software. Segments of
single-channel activity separated by long periods of baseline
were idealized into noise-free open and shut events using a
temporal resolution of 70 µs. Single-channel activations were
separated using a shut period (tcrit) ranging between 6 ms
and 30 ms, however most of the tcrit values were <10 ms.
Group data form current-voltage experiments were fitted to
a polynomial using Sigmaplot (Systat Software), from which
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reversal potential was obtained. Ohm’s Law was used to find
single-channel conductance (γ), in which Vhold is the holding
potential (−70 mV), V ljp is the liquid junction potential (4.7 mV
for the solutions used) and Vrev is the reversal potential as
follows: γ = (i)/(Vhold − V ljp − Vrev).
RESULTS
GlyR α2R323L Mutation Is Associated with
Autism, Loss of Acquired Language,
Seizures, Macrocephaly and
Hypothyroidism
Previously reported GLRA2 mutations associated with ASD
include a microdeletion (GLRA2∆ex8-9; Pinto et al., 2010) and
de novo missense mutations p.N109S (Iossifov et al., 2014) and
p.R126Q (Pilorge et al., 2016) identified in the hemizygous
state in males with non-syndromic autism. Additional clinical
symptoms were noted in two of these individuals, including
language delay with functional language and low average
IQ (GLRA2∆ex8-9) and hyperactivity, severe language delay
and tonic-clonic seizures (p.R126Q). These mutations were
classified as loss of function based on impaired cell-surface
expression of GlyR α2, and abolition (GLRA2∆ex8-9) or
markedly reduced sensitivity to glycine (p.N109S and p.R126Q;
Pilorge et al., 2016). These recessive mutations were not
found to be disease causing in female carriers, due to the
presence of a normal GLRA2 allele, and because GLRA2
escapes X-inactivation in the vast majority of tissues including
brain (Cotton et al., 2015). However, many mutations in
the GlyR α1 subunit gene (GLRA1) that cause startle disease
show dominant inheritance (Harvey et al., 2008; Bode and
Lynch, 2014). We therefore decided to examine the functional
effects of potentially pathogenic variants found in females.
In particular, we focussed on p.R323L (p.R350L in the GlyR
α2 subunit with signal peptide; c.1049G>T in NM_001118885).
This missense mutation was previously reported in a female
with ASD (Piton et al., 2011) that was predicted to be damaging
by a number of software packages (including PolyPhen-2,
SNPs&GO, MutPred, PANTHER and SIFT; Pilorge et al., 2016).
This mutation is also extremely rare, as it is not reported
in the Genome Aggregation Database (gnomAD1) currently
comprising 126,216 exome sequences and 15,136 whole-
genome sequences from unrelated individuals. The mutated
arginine is located the large M3–M4 intracellular loop of
the GlyR α2 subunit and is highly conserved among GlyR
subunits (Figure 1A). Additional clinical symptoms reported
in this case include loss of acquired words, seizures, mild
motor developmental delay, macrocephaly and hypothyroidism
(Gauthier, personal communication).
Effects of the α2R323L Mutation on GlyR
Channel Properties
To determine the functional effects of the GlyR α2R323L
mutation, we examined the potency of glycine in activating
1http://gnomad.broadinstitute.org/
FIGURE 1 | Effect of the Glycine receptor (GlyR) α2 subunit p.R323L
mutation examined by whole-cell patch-clamp recording.
(A) Alignments of vertebrate GlyR α2 subunit amino acid sequences indicating
the conserved arginine residue at position 323 (red). (B) Sample whole-cell
recordings for heteromeric α2β and α2R323Lβ GlyRs in the presence of
indicated glycine concentrations. (C) Averaged whole-cell glycine
dose-response curves for α2, α2β, α2R323L and α2R323Lβ GlyRs.
recombinant homomeric α2R323L and heteromeric α2R323Lβ
receptors. Figure 1B illustrates whole-cell currents recorded in
response to increasing concentrations of glycine in HEK293 cells
expressing wild-type GlyRs or those containing α2R323L. The
glycine dose-response curve of both homomeric α2R323L and
heteromeric α2R323Lβ GlyRs were modestly right-shifted, with
EC50 values of 67.9 ± 13.4 (α2R323L) and 143.0 ± 12.9 µM
(α2R323Lβ), compared with 46.6 ± 6.7 and 90.3 ± 14.6 µM
for the corresponding wild-type α2 and α2β GlyRs (Table 1,
Figure 1C). Thus, in both homomeric and heteromeric GlyRs,
the p.R323L mutation results in a small decrease in apparent
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TABLE 1 | Summary of dose-response analysis data for α2, α2β, α2R323L
and α2R323Lβ Glycine receptors (GlyRs).
α2 α2β α2R323L α2R323Lβ
EC50 µM 46.6 ± 6.7 90.3 ± 14.6 67.9 ± 13.4 143.0 ± 12.9∗
Hill slope 2.2 ± 0.1 2.1 ± 0.1 2.1 ± 0.2 2.0 ± 0.3
Imax (nA) 1.6 ± 0.2 2.1 ± 0.3 1.5 ± 0.4 1.7 ± 0.2
n 12 11 9 13
Statistical comparisons of α2R323L and α2R323Lβ were made relative to α2 and α2β
GlyRs, respectively, via an unpaired Student’s t-test. ∗p < 0.05.
glycine sensitivity. There was no significant difference in peak
whole-cell currents in all the receptors tested (range,∼2–1.5 nA,
Table 1) suggesting that mutations of R323 do not alter GlyR
cell-surface expression.
The GlyR α2R323L Mutation Alters Intrinsic
Channel Gating
This modest change in dose-response relationship is insufficient
to explain the pathogenic effects of the p.R323L mutation,
especially since the peak glycine concentration in the synaptic
cleft is thought to reach 1–3 mM in embryonic zebrafish
neurons (Legendre, 1998) and 2.2–3.5 mM in adult rat spinal
neurons (Beato, 2008). Clearance of glycine away from the
cleft has also been estimated to occur on a 0.6–0.9 ms
time scale (Beato, 2008). Based on these parameters, we
examined intrinsic channel properties by rapidly applying
saturating glycine (3 mM) for a period of ∼1 ms to
excised outside-out HEK293 cell patches expressing wild-type
and mutant α2R323Lβ receptors. Sample macroscopic currents
are shown in Figure 2A. The time course of deactivation
was fitted by a double exponential function with a mean
time constant of 61.9 ± 3.2 ms (n = 15) for α2β GlyRs
and a mean time constant of 87.9 ± 5.4 ms (n = 17)
for α2R323Lβ GlyRs (Figure 2B, Table 2). The deactivation
time constant for α2R323Lβ receptors was ∼1.5-fold slower
compared to wild-type GlyRs (p < 0.05). However, the rise
time did not differ between wild-type and mutant receptors
(α2β, 1.3 ± 0.1 ms; α2R323Lβ, 1.4 ± 0.2 ms; p > 0.05).
FIGURE 2 | Glycine-evoked α2R323Lβ currents have slower intrinsic
kinetic properties compared to wild-type α2β. (A) Averaged macropatch
currents recorded from outside-out patches containing α2β (black trace) and
α2R323Lβ (red trace) GlyRs. Currents were activated by brief (∼1 ms) exposure
to saturating (3 mM) glycine. To allow comparison of kinetic properties, the
currents were normalized to the same peak amplitude. (B) Comparison of
mean macropatch current decay time constants and 10%–90% rise times.
∗p < 0.05 relative to α2β GlyRs via unpaired Student’s t-test.
This suggests that the p.R323L mutation in M3–M4 loop
enhances channel function by slowing the channel closing
rate. An analysis of the individual components of the double
exponential fit revealed that the longer time constant and
the fraction of the total current it represents increased
(Table 3).
The GlyR α2R323L Mutation Alters
Glycinergic IPSC Kinetics
To test whether the enhancement of GlyR function altered
glycinergic transmission, we used a heterosynapse system that
allows control over the subunit composition of GlyRs in
glycinergic synapses (Zhang Y. et al., 2015). We inserted α2β
and α2R323Lβ GlyRs into heterosynapses in turn to evaluate
the properties of the resulting IPSCs. Sample IPSC recordings
from heterosynapses incorporating α2β and α2R323Lβ isoforms
are shown at different temporal resolution in Figure 3A with
averaged normalized IPSCs. The averaged IPSC amplitudes,
10%–90% rise times and decay time constants for α2β and
α2R323Lβ GlyRs are presented in Figure 3B and Table 2.
We observed that IPSCs mediated by α2R323Lβ receptors
displayed a 2-fold slower rise and decay time than those
mediated by wild-type α2β GlyRs (10%–90% rise time: α2β,
2.6 ± 0.3 ms, n = 7; α2R323Lβ, 4.9 ± 0.8 ms, n = 6,
p < 0.01; decay time: α2β, 27.0 ± 1.5 ms; α2R323Lβ,
60.8 ± 4.9 ms, p < 0.0001), whereas the mean IPSC amplitude
did not differ significantly (α2β, 32.8 ± 2.5 pA; α2R323Lβ,
34.0 ± 11.9 pA; p > 0.05). We also sought to investigate the
effects of the previously described autism mutations, α2N109S
and α2R126Q (Pilorge et al., 2016), in heterosynapses, but
heteromeric GlyRs incorporating these mutations yielded no
detectable synaptic currents (n > 10 cells expressing each
mutant GlyR). This result was expected given that both
mutations dramatically increased the glycine EC50 (Pilorge et al.,
2016).
The Nature of the Substitution at
R323 Governs the Time-Course of
Glycinergic IPSCs
We next sought to investigate whether the nature of the side
chain, charge or the steric characteristics of the p.R323L
substitution contributes directly to the observed increase in
intrinsic channel deactivation rates. Arginine is basic and
polar (positively charged) with a 3-carbon aliphatic straight
chain, capped at the distal end by a complex guanidinium
group. We replaced R323 by alanine (α2R323A) which is
aliphatic, uncharged and has a short side chain consisting
of a single methyl group. We also examined substitutions
with lysine (α2R323K, which is basic, and has a positively
charged ε-amino group) and isoleucine (α2R323I, aliphatic,
non-polar and differing from leucine only in the position
of a side chain methyl group). We then characterized
the effects of each GlyR α2 mutant on the kinetics of
heterosynaptic IPSCs. Figure 3C shows sample recordings
from heterosynapses incorporating the GlyR α2R323A, α2R323K
and α2R323I constructs, and averaged normalized IPSCs
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FIGURE 3 | The GlyR α2R323L mutation results in prolonged inhibitory postsynaptic currents (IPSCs) in inhibitory heterosynapses. (A) Representative
recordings of glycinergic IPSCs in HEK293 cells expressing α2β and α2R323Lβ GlyRs at different temporal resolutions. Normalized IPSCs each averaged
from >50 events from the corresponding cell are shown in the right panel (color traces). (B) Comparison of mean IPSC amplitude, decay time constant and
10%–90% rise time for the indicated GlyRs. (C) Representative recordings of glycinergic IPSCs in HEK293 cells expressing the α2R323Aβ, α2R323Kβ and α2R323Iβ
GlyRs at different temporal resolutions. Recordings were performed at −60 mV. Statistical significance was determined via one-way ANOVA followed by Bonferroni’s
post hoc correction with significance represented by ∗∗p < 0.01 and ∗∗∗∗p < 0.0001 relative to α2β GlyRs.
TABLE 2 | Comparison of 10%–90% rise times, decay time constants and maximal peak currents of inhibitory postsynaptic currents (IPSCs) and
macropatch currents mediated by the wild type and mutant GlyRs.
α2β α2R323Lβ α2R323Aβ α2R323Kβ α2R323Iβ
10%–90% rise time (ms) IPSCs 2.6 ± 0.3 (7) 4.9 ± 0.8∗∗ (6) 2.5 ± 0.3 (4) 2.3 ± 0.3 (7) 2.4 ± 0.1 (5)
macropatch currents 1.4 ± 0.1 (17) 1.3 ± 0.2 (15) – – –
Deactivation time constant (ms) IPSCs 27.0 ± 1.5 60.8 ± 4.9∗∗∗∗ 37.1 ± 6.8 32.3 ± 2.8 32.0 ± 2.5
macropatch currents 61.9 ± 3.2 87.9 ± 5.4∗ – – –
Imax (pA) IPSCs 32.8 ± 2.5 34.0 ± 11.9 24.3 ± 4.7 28.5 ± 3.3 18.2 ± 2.0
macropatch currents 381 ± 47 330 ± 76 – – –
∗p < 0.05, ∗∗p < 0.01 and ∗∗∗∗p < 0.0001 relative to the wild-type α2β GlyR, unpaired t-test for comparisons between two groups and one-way ANOVA followed by
Bonferroni’s post hoc correction for multiple comparisons. For IPSCs, n values refer to the total number of cells from which data were collected. For each cell, parameters
were analyzed from a single IPSC waveform that was digitally averaged from >50 individual events.
are presented in the right panel. All three substitutions
produced heterosynaptic IPSCs that had kinetics similar to
those of wild-type α2β GlyRs. Again, similar peak currents
between mutant and wild-type receptors in macropatch
and heterosynapse recordings suggests comparable surface
expression (Table 2).
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TABLE 3 | Individual time constants and relative areas for macropatch currents.
Receptor τ1 (ms) A1 τ2 (ms) A2 n
Wild-type α2 GlyR 132 ± 7 0.29 ± 0.03 34.4 ± 2.6 0.71 ± 0.03 8
α2R323Lβ GlyR 173 ± 14∗ 0.37 ± 0.03 37.7 ± 2.8 0.63 ± 0.02 7
Data represent mean ± SEM. ∗p < 0.05. The relative areas are expressed as a fractions.
The GlyR α2R323L Mutation Alters GlyR
Single-Channel Kinetics
Since another pathomechanism associated with GlyR
mutations is spontaneously-opening channels (Chung et al.,
FIGURE 4 | Single-channel amplitude of heteromeric α2β and α2R323Lβ
GlyRs. (A,B) Both α2β and α2R323Lβ GlyRs showed no significant
spontaneous activity in glycine-free solution (above). Activity in α2β and
α2R323Lβ receptors was observed in 100 µM glycine solution (below).
Amplitude histogram of α2β and α2R323Lβ (bottom panels) revealed that the
mutation produced a small but consistent increase in single-channel amplitude
(α2β, ∼3.2 pA, α2R323Lβ ∼3.8 pA). Recordings were performed at −70 mV
and channel openings are shown as downward deflections.
2010; Bode et al., 2013; James et al., 2013; Zhang et al.,
2016), we examined the activity of α2β and α2R323Lβ
GlyRs in outside-out patches. No spontaneous activity was
observed when patches containing α2β and α2R323Lβ GlyRs
were perfused with glycine-free solution for more than
1 min (Figures 4A,B above). However, at a saturating
100 µM glycine concentration, active periods were induced
and observed as clusters of openings (Figures 4A,B). The
current amplitude at −70 mV was determined for α2β
and α2R323Lβ GlyRs by plotting amplitude histograms and
fitting these to Gaussian functions. GlyRs containing the
α2β subunit combination displayed currents of ∼3.2 pA,
whereas single-channel currents for α2R323Lβ GlyRs were
∼3.8 pA at −70 mV (Figures 4A,B below). The single-
channel conductance was determined for both α2β and
α2R323Lβ GlyRs by carrying out current-voltage experiments
over a range of voltages from −70 mV to +70 mV and
averaged from three to five patches (Figures 5A,B). Mild
inward rectification was observed in the current-voltage
plots of both channels (Figures 5C,D). Current-voltage
plots for heteromeric α2β and α2R323Lβ GlyRs intersected
the voltage axis at ∼+3 mV (Figure 5C) and ∼+5.5 mV
(Figure 5D), respectively. Mean single-channel conductance
levels were calculated to be 41.2 pS for α2β and 47.5 pS for
α2R323Lβ and were statistically different (p < 0.05). Thus,
the conductance of α2R323Lβ GlyRs is slightly larger than
that for wild-type α2β GlyRs, but less than that previously
reported for homomeric α2 subunit GlyRs (60–120 pS;
Wang et al., 2006; Krashia et al., 2011).
Finally, we investigated single-channel kinetics for α2β
and α2R323Lβ GlyRs. Samples of opening durations for α2β
and α2R323Lβ are shown in Figures 6A,B, respectively. The
duration of activations and open probabilities (Po) for two
channel types were assessed at 100 µM and 3 mM glycine
(Table 4). At both concentrations, the mean duration of
active periods for α2R323Lβ GlyRs was longer than that
observed for α2β GlyRs (Figure 6C). It is noteworthy
that there was a high standard deviation in the values
for wild-type α2β GlyRs at 3 mM glycine. Although the
Po values of the two receptors were indistinguishable at
3 mM glycine, at 100 µM glycine α2R323Lβ showed a
significant increase in Po compared to α2β (Figure 6D).
In summary, the increase in decay times for synaptic
and macropatch currents, the small but significant increase
in single-channel conductance and the prolongation of
individual receptor active periods clearly demonstrates
that overall, the R323L mutation confers a gain-of-
function.
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FIGURE 5 | Current-voltage and conductance characteristics of heteromeric α2β and α2R323Lβ GlyRs. Sample currents obtained at the indicated pipette
voltages for heteromeric α2β (A) and α2R323Lβ GlyRs (B). Current-voltage relationships of heteromeric α2β (C) and α2R323Lβ (D) GlyRs, obtained from averaged data
from three to five patches.
TABLE 4 | Single-channel activation parameters of α2β and α2R323Lβ receptors.
Opening probabilities (Po) Mean duration of active periods (ms)
Channel 100 µM glycine 3 mM glycine 100 µM glycine 3 mM glycine
α2β 0.73# 0.76 ± 0.02 165 ± 21 242 ± 102
α2R323Lβ 0.85 ± 0.02 0.82 ± 0.02 277 ± 37∗ 360 ± 44
Data represent mean (n = 3–4) ± SEM. ∗p < 0.05, #from n = 2 patches.
DISCUSSION
We have described the detailed functional characterization
of the GlyR α2 subunit p.R323L mutation associated with
autism, macrocephaly, loss of acquired language, epilepsy and
hypothyroidism. We used a combination of rapid glycine
application, heterosynapses and single-channel recordings to
quantify the intrinsic channel properties and IPSC kinetic
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FIGURE 6 | Duration of single-channel activations in heteromeric α2β and α2R323Lβ GlyRs. Single-channel currents at the indicated concentrations of glycine
for patches expressing heteromeric α2β (A) and α2R323Lβ GlyRs (B). Bar plots of the durations of active periods (C) and open probability (D) at the indicated glycine
concentrations. Note that mutant α2R323Lβ GlyRs activate in clusters with a longer opening duration compared to wild-type α2β GlyRs. ∗p < 0.05.
properties of α2R323Lβ GlyRs. We found that the p.R323L
mutation resulted in a small apparent decrease in glycine
sensitivity in α2R323L and α2R323Lβ GlyRs (Figure 1, Table 1).
Notably, this was not of the same order of magnitude previously
observed for the GlyR α2N109S and α2R126Q loss-of-function
mutations (Pilorge et al., 2016). Using outside-out patches, we
found that the p.R323L mutation did not alter rise time, but
slowed the deactivation time constant of α2R323LβGlyRs by∼1.5-
fold compared to wild-type α2β GlyRs (Figure 2, Table 2). We
also examined properties of GlyR α2R323Lβ GlyRs in glycinergic
heterosynapses that were formed between presynaptic terminals
of cultured spinal glycinergic interneurons and HEK293 cells
expressing recombinant GlyRs. As well as allowing control
over the subunit composition of the GlyRs under study, the
electrotonically compact shape of HEK293 cells allows IPSC
waveforms to be resolved with high fidelity (Dixon et al., 2015;
Zhang Y. et al., 2015). IPSCs mediated by α2R323Lβ receptors in
heterosynapses displayed a 2-fold slower rise and decay time than
those mediated by wild-type α2β GlyRs, whereas the mean IPSC
amplitude did not differ significantly (Figure 3, Table 3). As the
change in IPSC decay rates corresponds well with the duration
of single receptor active periods in the α2R323Lβ receptors, we
infer that the slower decay of IPSCs is dominated by the intrinsic
gating properties of the channels. We next sought to understand
whether the nature of the amino acid at position 323 is vital
for the effect on ion channel function, replacing the basic
and positively charged R323 by alanine (aliphatic, uncharged,
short side chain), lysine (also basic and positively charged)
and isoleucine (aliphatic, non-polar) and measuring the effects
on heterosynaptic IPSCs. Surprisingly, all three substitutions
resulted in GlyRs with wild-type characteristics (Figure 3,
Table 2). This suggests that the bulky side chain at position
R323 did not generate steric interactions with the adjacent GlyR
subunits, and electrostatic mechanisms are not responsible for
prolonged IPSC time courses observed in α2R323Lβ GlyRs.
Finally, we examined the properties of α2β and α2R323Lβ
GlyRs using single-channel recordings (Figures 4–6),
excluding the possibility that these mutant GlyRs resulted
in spontaneously-opening channels, a known pathomechanism
in startle disease involving GlyR α1β dysfunction (Chung
et al., 2010; Bode et al., 2013; James et al., 2013; Zhang et al.,
2016). Mean single-channel conductances were 41.2 pS for
α2β and 47.5 pS for α2R323Lβ (Table 3) suggesting that the
conductance of α2R323Lβ GlyRs is slightly, but significantly
larger than that for wild-type α2β GlyRs. Moreover, the duration
of activations and opening probability (Po) at 100 µM were
also increased (Figure 6, Table 3), suggesting that α2R323Lβ
GlyRs spend more time in conducting states while active and
were active for longer periods than wild-type α2β GlyRs. A
single-channel study that examined α2 homomeric GlyRs
concluded that these receptors exhibited longer active periods
(mean open times) compared to adult synaptic α1β heteromeric
GlyRs (Krashia et al., 2011). Another study that measured the
duration of single-channel active periods estimated a mean
duration of ∼500 ms for α1β heteromeric GlyRs, however, the
active periods were isolated using longer shut periods (tcrit)
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FIGURE 7 | Functionally-important residues and disease-causing mutations in GlyR intracellular loops. M3–M4 loop sequences of human GlyR
α1-α3 subunits and alternatively spliced variants (α1S, α1L, α3S and α3L) are shown. Bold letters indicate residues that have been investigated in vitro for: structure
(α-helical elements), ion permeation and desensitization (portals), nuclear localization signals (NLS), GlyR topology, binding of intracellular proteins (Gβγ) or
pharmacological agents such as cannabinoids (CB) and ethanol (EtOH), phosphorylation by PKC or PKA or ubiquitination (Ub). Mutations found in human patients
with autism (GlyR α2) or startle disease (GlyR α1) are indicated in bold red type. Modified from Langlhofer and Villmann (2016).
(Scott et al., 2015). Taken together, these data strongly suggest
that the p.R323L mutation results in an overall gain-of-function,
although uniquely the resulting GlyRs do not show spontaneous
channel openings. This may explain why this mutation is
pathogenic even in the heterozygous state, and relates to some
of the unique clinical features seen in this individual, including
autism, macrocephaly and epilepsy. Autism has been associated
with signs of cortical enlargement in children as young as
6 months of age and precedes brain overgrowth observed
at 1–2 years of age (Hazlett et al., 2017). Autism, language
delay and seizures have previously been associated with other
human GlyR α2 mutations (Pilorge et al., 2016) and mouse
models suggest that these features could arise from defects
in cortical neuronal migration and/or dendritic branching,
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resulting in disrupted excitatory/inhibitory balance (Avila et al.,
2013, 2014; Morelli et al., 2017). Given that loss-of-function
of GlyR α2 leads to microcephaly in knockout mice (Avila
et al., 2014), we speculate that the overall gain-of-function we
observed for GlyR α2R323L results in macrocephaly in the index
patient.
One question that remains is why the p.R323L mutation is
pathogenic in the index patient, but not in her mother, who is
also a heterozygous carrier of the mutation. Here we note that
although GlyR dysfunction has not previously been linked to
hypothyroidism, this condition delays the development of the
hyperpolarizing shift in the Cl− equilibrium potential during
neuronal development, which in turn delays the maturation of
GABAergic and glycinergic synaptic inhibition (Friauf et al.,
2008). This is thought to explain the link between thyroid
hormone deficiency and functional deficits in the nervous
system (Friauf et al., 2008). Thus, one possibility is that the
hypothyroidism in this patient could delaying the switch from
excitatory to inhibitory synaptic transmission, thus exacerbating
the effects of the GlyR α2 p.R323L mutation and prolonging
the period of disrupted cortical neuronal migration. This
hypothesis could be tested in future knock-in models for GlyR
α2R323L bymeasuring cortical neuronal migration and progenitor
homeostasis, since hypothyroidism can be induced in animal
models (Friauf et al., 2008).
Our study also underlines the importance of the GlyR
intracellular M3–M4 loop in GlyR function (Langlhofer and
Villmann, 2016). This region in GlyRs has been studied
extensively (Figure 7). It is known to have α-helical elements
(Burgos et al., 2015) and is involved in phosphorylation (Harvey
et al., 2004; Manzke et al., 2010; Han et al., 2013), intracellular
sorting (Melzer et al., 2010), protein-protein interactions (Meyer
et al., 1995; Melzer et al., 2010; Del Pino et al., 2014; Burgos et al.,
2015), subunit topology (Sadtler et al., 2003) and modulation
by Gβγ, ethanol and cannabinoids (CB; Yevenes et al., 2008;
Yevenes and Zeilhofer, 2011; Burgos et al., 2015; Sanchez
et al., 2015). Others have highlighted the importance of the
GlyR M3–M4 intracellular loop in desensitization behavior
(Nikolic et al., 1998), channel gating (Breitinger et al., 2009)
and conductance (Carland et al., 2009). Of these, the GlyR
α2 p.R323L substitution only overlaps with motifs involved in
GlyR topology and/or Gβγ modulation in the GlyR α1 subunit.
Since our data demonstrate that the GlyR α2R323L reaches the
membrane and is functional, it is unlikely that this mutation
drastically affects GlyR topology. In addition, GlyR α2 is
not modulated by Gβγ (Yevenes et al., 2010). Lastly, GlyR
α2 p.R323L does not correspond to the position of any known
startle disease missense mutation located in the M3–M4 loop
(Figure 7), although a nonsense mutation (p.R316X) was
reported (Tsai et al., 2004) at the same position in the GlyR
α1 subunit. Given the effects of the GlyR α2 p.R323L mutation
on channel conductance properties, intrinsic channel gating
and IPSC kinetics, we suggest that this residue is a potential
determinant of theoretical intracellular portals consisting of
charged residues influencing ion permeation and conductance
(Carland et al., 2009). Previously, these elements were thought
to be localized at the C-terminal end of the GlyR α1 subunit
M3–M4 loop, where mutation of selected positively-charged
residues (e.g., R377, K378, K385 and K386) to negatively-
charged residues gave rise to non-functional channels (Carland
et al., 2009). Our study provides new evidence suggesting
that positively-charged residues at the N-terminal end of the
M3–M4 loop may have a key role to play in the control
of IPSC rise and decay times, and mean channel opening
durations.
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